Neutralizing Antibodies Targeting HIV-1 gp41

HIV-1 vaccine research has obtained an enormous boost since the discovery of many broadly neutralizing antibodies (bnAbs) targeting all accessible sites on the HIV-1 envelope glycoprotein (Env). This in turn facilitated high-resolution structures of the Env glycoprotein in complex with bnAbs. Here w...

Descripción completa

Detalles Bibliográficos
Autores principales: Caillat, Christophe, Guilligay, Delphine, Sulbaran, Guidenn, Weissenhorn, Winfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690876/
https://www.ncbi.nlm.nih.gov/pubmed/33114242
http://dx.doi.org/10.3390/v12111210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690876/
https://www.ncbi.nlm.nih.gov/pubmed/33114242
http://dx.doi.org/10.3390/v12111210

Ejemplares similares